Impact of Baseline Smoking Status and Body Mass Index in Patients with Hidradenitis Suppurativa Treated with Adalimumab or Placebo in Phase 2 or 3 Studies. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s130. https://doi.org/10.25251/skin.1.supp.129